GMAB
Genmab - ADR

1,082
Mkt Cap
$16.11B
Volume
1.03M
52W High
$35.43
52W Low
$17.24
PE Ratio
16.76
GMAB Fundamentals
Price
$26.14
Prev Close
$26.57
Open
$26.61
50D MA
$30.94
Beta
0.65
Avg. Volume
1.67M
EPS (Annual)
$1.55
P/B
2.75
Rev/Employee
$1.23M
$23,019.96
Loading...
Loading...
News
all
press releases
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Average Rating of "Moderate Buy" from Brokerages
Genmab A/S Sponsored ADR (NASDAQ:GMAB - Get Free Report) has been given an average recommendation of "Moderate Buy" by the ten brokerages that are currently covering the firm, MarketBeat reports. One...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Short Interest in Genmab A/S (OTCMKTS:GNMSF) Increases By 58.8%
Genmab A/S (OTCMKTS:GNMSF - Get Free Report) was the target of a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 145,224...
MarketBeat·3d ago
News Placeholder
First Trust Advisors LP Sells 82,922 Shares of Genmab A/S Sponsored ADR $GMAB
First Trust Advisors LP trimmed its stake in shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) by 4.7% in the 3rd quarter, according to its most recent disclosure with the Securities...
MarketBeat·4d ago
News Placeholder
Genmab A/S (NASDAQ:GMAB) Now Covered by Wells Fargo & Company
Wells Fargo & Company began coverage on shares of Genmab A/S in a research report on Monday. They set an "overweight" rating and a $40.00 price objective on the stock...
MarketBeat·13d ago
News Placeholder
Guggenheim Cuts Genmab A/S (NASDAQ:GMAB) Price Target to $40.00
Guggenheim reduced their price target on Genmab A/S from $45.00 to $40.00 and set a "buy" rating for the company in a report on Monday...
MarketBeat·20d ago
News Placeholder
Q1 Earnings Forecast for Genmab A/S Issued By HC Wainwright
Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) - Equities researchers at HC Wainwright dropped their Q1 2026 earnings per share estimates for Genmab A/S in a report released on Wednesday...
MarketBeat·23d ago
News Placeholder
Genmab A/S (NASDAQ:GMAB) Announces Earnings Results
Genmab A/S (NASDAQ:GMAB - Get Free Report) posted its earnings results on Tuesday. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.46...
MarketBeat·25d ago
News Placeholder
Genmab A/S (NASDAQ:GMAB) Price Target Raised to $40.00 at HC Wainwright
HC Wainwright lifted their target price on Genmab A/S from $39.00 to $40.00 and gave the stock a "buy" rating in a research report on Wednesday...
MarketBeat·25d ago
News Placeholder
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Get Free Report) have earned an average rating of "Moderate Buy" from the ten research firms that are covering the stock, MarketBeat.com reports. One...
MarketBeat·26d ago
News Placeholder
Genmab A/S Q4 Earnings Call Highlights
Genmab A/S (NASDAQ:GMAB) executives told investors the company delivered on its 2025 priorities of accelerating late-stage pipeline development, maximizing commercial medicines, and executing its...
MarketBeat·26d ago
<
1
2
...
>

Latest GMAB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.